Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Rotator Cuff Evaluation And Classification of Tendinopathy (REACT Cohort) (REACT)

15 listopada 2026 zaktualizowane przez: Weiliang Shen, Ph.D., M.D., Second Affiliated Hospital, Zhejiang University, School of Medicine

Clinical Classification, Molecular Mechanisms, and Outcomes After Arthroscopic Rotator Cuff Repair: A Prospective Observational Cohort Study

Rotator cuff tears can cause shoulder pain, weakness, and difficulty with daily activities. Although arthroscopic rotator cuff repair helps many patients, recovery varies. Some patients continue to experience pain, shoulder stiffness, or incomplete tendon healing.

The REACT cohort will follow approximately 1,000 adults aged 18 to 75 years who are scheduled for their first arthroscopic rotator cuff repair at the Second Affiliated Hospital, Zhejiang University School of Medicine, China. The study will examine how patients' health, lifestyle, shoulder imaging, tissue characteristics, surgical findings, and rehabilitation are associated with recovery.

Information will be collected before surgery and at 3, 6, 12, 24, and 60 months after surgery. Assessments will include shoulder symptoms and function, quality of life, physical examination, tendon healing on magnetic resonance imaging, additional treatments, and medical events. With appropriate consent, blood and small amounts of tissue that would otherwise be removed during routine surgery will be retained for laboratory research.

The investigators hypothesize that differences in clinical and biological characteristics identify rotator cuff tendinopathy subtypes associated with different recovery patterns. The study aims to improve classification and prediction of outcomes and to identify potential targets for future research. Treatment decisions will be made by patients and their treating clinicians as part of usual care. The study will not assign treatments, and computer-predicted candidate drugs will not be administered as part of this cohort.

Przegląd badań

Status

Jeszcze nie rekrutacja

Warunki

Interwencja / Leczenie

Typ studiów

Obserwacyjny

Zapisy (Szacowany)

1000

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Zhejiang
      • Hangzhou, Zhejiang, Chiny
        • The Second Affiliated Hospital of Zhejiang University
        • Kontakt:

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 75 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Metoda próbkowania

Próbka bez prawdopodobieństwa

Badana populacja

Adults aged 18 to 75 years with an MRI-confirmed rotator cuff tear who are scheduled for arthroscopic rotator cuff repair at the Department of Orthopaedic Surgery and Sports Medicine, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Consecutive eligible patients will be approached during the recruitment period and enrolled after providing written informed consent. Participants will receive usual clinical care and undergo standardized assessments before surgery and at 3, 6, 12, 24, and 60 months after surgery. The cohort will investigate clinical and biological characteristics associated with shoulder symptoms, function, and tendon healing.

Opis

Inclusion Criteria:

  • Age 18 to 75 years.
  • Rotator cuff tear confirmed by magnetic resonance imaging and scheduled for arthroscopic rotator cuff repair.
  • Willing to participate in the cohort and able to provide written informed consent.
  • Willing and able to comply with the scheduled follow-up assessments.

Exclusion Criteria:

  • No definite rotator cuff tear on magnetic resonance imaging or no clinical indication for rotator cuff repair.

Calcific tendinopathy as the primary diagnosis without a definite rotator cuff tear.

Concomitant neuropathy affecting the shoulder, symptomatic cervical spine disease, or hemiplegia.

Concomitant shoulder dislocation, fracture, or severe osteoarthritis.

Previous surgery on the ipsilateral shoulder.

Severe systemic disease, including systemic inflammatory disease such as rheumatoid arthritis.

A serious or terminal illness that is expected to prevent completion of the study.

Cognitive or communication impairment that prevents adequate understanding of the study or participation in study assessments.

Pregnancy, planned pregnancy, or breastfeeding.

A contraindication to magnetic resonance imaging.

Planned surgery primarily for labral repair, shoulder stabilization, or acromioplasty rather than rotator cuff repair.

A diagnosed infectious disease.

Participation in another clinical research study within the preceding three months.

Any other condition that, in the investigator's judgment, makes participation inappropriate.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Modele obserwacyjne: COHORT
  • Perspektywy czasowe: PROSPECTIVE

Kohorty i interwencje

Grupa / Kohorta
Interwencja / Leczenie
Arthroscopic Rotator cuff Repair

Adults aged 18 to 75 years with an MRI-confirmed rotator cuff tear who are scheduled for primary arthroscopic rotator cuff repair. Participants will receive usual clinical care and undergo standardized longitudinal assessment. Clinical, imaging, surgical, rehabilitation, and biospecimen data will be used to investigate tendinopathy subtypes and factors associated with postoperative outcomes.

Primary arthroscopic rotator cuff repair performed for a clinical indication. Repair configuration, suture anchors, management of the long head of the biceps, acromioplasty, capsular release, and postoperative rehabilitation will be determined by the treating team and recorded. The research protocol does not assign the procedure, its technical components, or subsequent treatment.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Oxford Shoulder Score
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Patient-reported shoulder pain and function assessed using the 12-item Oxford Shoulder Score (OSS). The questionnaire evaluates shoulder symptoms and their effects on daily activities over the preceding four weeks. Total scores range from 0 to 48, with higher scores indicating less pain and better shoulder function. Scores will be evaluated at each scheduled assessment to characterize postoperative recovery over time.

Baseline and 3, 6, 12, 24, and 60 months after surgery.

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Constant-Murley Score
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Shoulder pain, activities of daily living, range of motion, and muscle strength assessed using the Constant-Murley Score (CMS). Total scores range from 0 to 100, with higher scores indicating better shoulder function. Scores will be evaluated at each scheduled assessment to characterize recovery over time.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
American Shoulder and Elbow Surgeons Score
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Patient-reported shoulder pain and functional limitations assessed using the American Shoulder and Elbow Surgeons (ASES) score. The score combines pain assessment with ten items evaluating daily activities. Total scores range from 0 to 100, with higher scores indicating less pain and better shoulder function.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Average Shoulder Pain Over the Previous 24 Hours
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Average shoulder pain over the preceding 24 hours assessed using a visual analogue scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain. Higher scores indicate greater pain intensity.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Shoulder Pain at Rest
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Shoulder pain at rest over the preceding week assessed using a visual analogue scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain. Higher scores indicate greater resting pain.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Shoulder Pain at Night
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Shoulder pain at night over the preceding week assessed using a visual analogue scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain. Higher scores indicate greater nighttime pain.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Shoulder Pain During Activity
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Shoulder pain during activity over the preceding week assessed using a visual analogue scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain. Higher scores indicate greater activity-related pain.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
EQ-5D-5L Health Status Profile
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Health-related quality of life assessed using the five-level EQ-5D questionnaire. The questionnaire measures mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has five levels, ranging from no problems to extreme problems or inability to perform the activity. Higher dimension levels indicate greater health problems.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Insomnia Severity Index
Ramy czasowe: Baseline and 3, 6, and 12 months after surgery.

The nature, severity, and impact of insomnia assessed using the seven-item Insomnia Severity Index (ISI). Each item is scored from 0 to 4, yielding a total score ranging from 0 to 28. Higher scores indicate more severe insomnia.

Baseline and 3, 6, and 12 months after surgery.
Tampa Scale of Kinesiophobia 5-Item Version
Ramy czasowe: Baseline and 3, 6, and 12 months after surgery.

Fear of movement and reinjury assessed using the 5-item Tampa Scale of Kinesiophobia (TSK-5). Total scores range from 5 to 20, with higher scores indicating greater fear of movement, concern about reinjury, and movement avoidance.

Baseline and 3, 6, and 12 months after surgery.
Pain Self-Efficacy Questionnaire Two-Item Version
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Confidence in performing activities despite pain assessed using the two-item Pain Self-Efficacy Questionnaire (PSEQ-2). Total scores range from 0 to 12, with higher scores indicating greater confidence in functioning despite pain.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Shoulder Activity Level
Ramy czasowe: Baseline and 12, 24, and 60 months after surgery.

Shoulder activity assessed using the protocol-specified shoulder activity scale. The scale evaluates the frequency of lifting, overhead activity, strength training, arm-swinging activity, and heavier carrying. Total scores range from 0 to 20, with higher scores indicating greater shoulder activity.

Baseline and 12, 24, and 60 months after surgery.
Shoulder Range of Motion
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Active and passive shoulder range of motion assessed by standardized physical examination, including forward elevation, abduction, and internal and external rotation. Angular measurements will be reported in degrees. Behind-the-back internal rotation will be recorded separately as the highest anatomical level reached. Each movement will be analyzed separately.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Shoulder Muscle Strength
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Shoulder forward-elevation and abduction strength assessed using standardized strength testing. Strength measurements for each movement will be recorded and analyzed separately, with higher measured force indicating greater muscle strength.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Rotator Cuff Tendon Integrity on Magnetic Resonance Imaging
Ramy czasowe: 24, and 60 months after surgery. Applicable for 6 and 12 months

Structural integrity of the repaired rotator cuff assessed using the Sugaya classification on postoperative magnetic resonance imaging. Tendons will be classified from type I to type V according to tendon thickness, signal characteristics, and continuity. The distribution of Sugaya categories will be reported at each assessment.

24, and 60 months after surgery. Applicable for 6 and 12 months
Rotator Cuff Retear on Magnetic Resonance Imaging
Ramy czasowe: 24, and 60 months after surgery. Applicable for 6 and 12 months

Number and proportion of participants with a structural retear of the repaired rotator cuff on postoperative magnetic resonance imaging. Retear will be defined as Sugaya type IV or V, indicating tendon discontinuity. Imaging will be independently reviewed by at least two assessors, with disagreements adjudicated by a senior assessor.

24, and 60 months after surgery. Applicable for 6 and 12 months
Patient Acceptable Symptom State
Ramy czasowe: 3, 6, 12, 24, and 60 months after surgery.

Patient-reported acceptability of the current shoulder symptom state, assessed using a direct question about whether the participant considers the current condition satisfactory or acceptable. The number and proportion of participants reporting an acceptable symptom state will be reported at each assessment.

3, 6, 12, 24, and 60 months after surgery.
Patient Satisfaction With Shoulder Recovery
Ramy czasowe: 3, 6, 12, 24, and 60 months after surgery.

Patient-reported satisfaction with shoulder recovery assessed using the study-specific satisfaction question. The distribution of responses across the questionnaire's satisfaction categories will be reported at each scheduled assessment.

3, 6, 12, 24, and 60 months after surgery.
Patient-Reported Global Improvement
Ramy czasowe: 3, 6, 12, 24, and 60 months after surgery.

Patient-perceived overall improvement or deterioration in shoulder symptoms and function compared with the preoperative condition, assessed using the study-specific global improvement question. The distribution of responses will be reported at each assessment.

3, 6, 12, 24, and 60 months after surgery.
Return to Preoperative Work Demands
Ramy czasowe: 3, 6, 12, 24, and 60 months after surgery.

Number and proportion of participants who report returning to their preoperative work demands among those working before surgery. Return to work and reasons for not returning will be recorded at each assessment.

3, 6, 12, 24, and 60 months after surgery.
Return to Preoperative Daily Activity Demands
Ramy czasowe: 3, 6, 12, 24, and 60 months after surgery.

Number and proportion of participants who report returning to their preoperative level of usual daily activity demands. Recovery status and reasons for not returning to the previous activity level will be recorded at each assessment.

3, 6, 12, 24, and 60 months after surgery.
Falls During Postoperative Follow-Up
Ramy czasowe: Postoperative follow-up through 60 months, with assessments at 12, 24, and 60 months.

Occurrence of patient-reported falls during postoperative follow-up. The number of reported falls and the number and proportion of participants experiencing at least one fall will be summarized over the applicable follow-up intervals.

Postoperative follow-up through 60 months, with assessments at 12, 24, and 60 months.
Additional Treatments for the Index Shoulder
Ramy czasowe: From surgery through 60 months, assessed at 3, 6, 12, 24, and 60 months.

Number and proportion of participants receiving additional treatments for the operated shoulder, including injections, additional rehabilitation, or other interventions. Treatment type, timing, and indication will be recorded and summarized separately by treatment category.

From surgery through 60 months, assessed at 3, 6, 12, 24, and 60 months.
Reoperation on the Index Shoulder
Ramy czasowe: From surgery through 60 months, assessed at 3, 6, 12, 24, and 60 months.

Number and proportion of participants undergoing additional surgery on the operated shoulder. The date, indication, and type of reoperation will be recorded.

From surgery through 60 months, assessed at 3, 6, 12, 24, and 60 months.
Adverse Events and Serious Adverse Events
Ramy czasowe: From informed consent through the final follow-up, up to 60 months after surgery.

Number and proportion of participants experiencing adverse events and serious adverse events. Event type, onset, severity, management, outcome, and possible relationship to routine treatment or research procedures will be recorded.

From informed consent through the final follow-up, up to 60 months after surgery.
Work Absenteeism Due to the Shoulder Condition
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.

Percentage of work time missed because of the shoulder condition during the preceding seven days, assessed using the Work Productivity and Activity Impairment Questionnaire-Specific Health Problem (WPAI-SHP). Absenteeism is calculated as hours missed because of the shoulder condition divided by the sum of those hours and hours actually worked, multiplied by 100. Scores range from 0% to 100%, with higher scores indicating greater work time loss. This outcome applies to employed participants with a nonzero denominator.

Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.
Work Presenteeism Due to the Shoulder Condition
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.

Percentage impairment in productivity while working because of the shoulder condition during the preceding seven days, assessed using the WPAI-SHP. The work productivity impairment item is scored from 0 to 10 and multiplied by 10 to obtain a percentage. Scores range from 0% to 100%, with higher scores indicating greater impairment. This outcome applies to participants who worked during the recall period.

Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.
Overall Work Productivity Loss Due to the Shoulder Condition
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.

Overall percentage of work productivity lost because of the shoulder condition during the preceding seven days, assessed using the WPAI-SHP. This outcome combines work absenteeism and impairment while working using the questionnaire's scoring algorithm. Scores range from 0% to 100%, with higher scores indicating greater overall work productivity loss. This outcome will be calculated for employed participants with sufficient applicable responses.

Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.
Non-Work Activity Impairment Due to the Shoulder Condition
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.

Percentage impairment in usual non-work activities because of the shoulder condition during the preceding seven days, assessed using the WPAI-SHP. Activities include housework, shopping, caring for family, exercise, and social activities. The activity impairment item is scored from 0 to 10 and multiplied by 10 to obtain a percentage. Scores range from 0% to 100%, with higher scores indicating greater activity impairment. This outcome applies regardless of employment status.

Baseline and 3, 6, 12, 24, and 60 months after surgery; seven-day recall at each assessment.
Reduction in Employment Due to the Shoulder Condition
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Number and proportion of participants reporting that their employment level has been reduced because of the shoulder condition, assessed using the supplementary employment question. Responses are recorded as yes or no.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Duration of Work Absence After Surgery
Ramy czasowe: 3, 6, 12, 24, and 60 months after surgery.

Patient-reported duration of absence from paid work after rotator cuff repair, recorded in months using the supplementary employment question. This outcome applies to participants employed before surgery. Participants who have not returned to work will be identified separately at each assessment.

3, 6, 12, 24, and 60 months after surgery.
Usual Weekly Working Hours
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Patient-reported usual number of hours worked per week, recorded using the supplementary employment question. Working hours will be summarized among participants in paid employment at each assessment.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Monthly Personal Income
Ramy czasowe: Baseline and 3, 6, 12, 24, and 60 months after surgery.

Patient-reported current monthly personal income, recorded in Chinese yuan using the supplementary income question. Income will be summarized at each assessment to describe economic circumstances over follow-up.

Baseline and 3, 6, 12, 24, and 60 months after surgery.
Number of Shoulder-Related Outpatient Visits
Ramy czasowe: The three months before baseline and the intervals ending at 3, 6, 12, 24, and 60 months after surgery.

Number of outpatient visits related to the index shoulder condition during each assessment interval, obtained from participant reports and available medical records. Visits for assessment, follow-up, or treatment will be counted. The number of visits within each interval and the cumulative number after surgery will be summarized.

The three months before baseline and the intervals ending at 3, 6, 12, 24, and 60 months after surgery.
Number of Shoulder-Related Hospital Admissions
Ramy czasowe: The three months before baseline and the intervals ending at 3, 6, 12, 24, and 60 months after surgery.

Number of inpatient admissions related to the index shoulder condition during each assessment interval, obtained from participant reports and available medical records. The admission for the index rotator cuff repair will be recorded separately and excluded from postoperative admission counts. The number of admissions within each interval and the cumulative number after surgery will be summarized.

The three months before baseline and the intervals ending at 3, 6, 12, 24, and 60 months after surgery.
Histopathological Characteristics of Rotator Cuff and Periarticular Tissues
Ramy czasowe: Tissue samples collected at the time of surgery.

Histopathological characteristics of surgically obtained tendon and periarticular tissue samples will be evaluated using standardized histological and immunohistochemical methods. This is an exploratory parameter. The patient tissue samples will be embedded using paraffin. Depending on the requirements of the subsequent studies, they will undergo HE staining or immunohistochemical staining to observe their characteristics.

Tissue samples collected at the time of surgery.
Peripheral Blood Immune Cell Profiles
Ramy czasowe: Blood samples collected at baseline before surgery.

Peripheral blood mononuclear cells (PBMCs) will be analyzed using flow cytometry to characterize circulating immune cell populations and their phenotypic features. Measurements may include the proportions and/or absolute counts of major lymphocyte and monocyte subsets and selected immune or inflammatory cell populations. Immune profiles will be explored in relation to tissue inflammation, molecular phenotypes, and clinical outcomes.

Blood samples collected at baseline before surgery.
Molecular Classification of Rotator Cuff Tendinopathy
Ramy czasowe: Tissue samples collected at surgery, with clinical outcomes assessed during postoperative follow-up through 60 months.

Tendinopathy subtypes will be characterized by integrating histopathological, transcriptomic, and other molecular features obtained from surgically collected tissues. Molecular classifications will be examined in relation to intraoperative tissue characteristics, imaging findings, clinical presentation, and postoperative recovery to identify biologically distinct phenotypes of rotator cuff disease.

Tissue samples collected at surgery, with clinical outcomes assessed during postoperative follow-up through 60 months.
Presence of Glenohumeral Capsular Adhesions
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Capsular adhesions will be assessed during arthroscopic surgery and recorded as present or absent using a standardized surgical case report form (CRF). The number and percentage of participants with capsular adhesions will be reported.

During the arthroscopic surgery (intraoperative assessment)
Presence of Glenoid Labral
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Glenoid labral injury will be assessed by direct arthroscopic observation and classified as present or absent. The number and percentage of participants with labral injury will be reported.

During the arthroscopic surgery (intraoperative assessment)
Distribution of Rotator Interval Synovial Villous Hypertrophy Grades
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Synovial villous hypertrophy in the rotator interval will be evaluated arthroscopically according to the predefined surgical CRF. The degree of villous hypertrophy will be classified by villous size as less than 2 mm, 2-5 mm, or greater than 5 mm. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Distribution of Glenohumeral Synovial Hyperemia Grades
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Synovial hyperemia within the glenohumeral joint will be assessed by arthroscopic observation and classified as colorless or transparent, mildly red, or markedly red. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Distribution of Long Head of the Biceps Tendon Integrity Categories
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

The integrity of the long head of the biceps tendon will be assessed arthroscopically and categorized as intact, partially torn, or completely torn. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Distribution of Subacromial Synovial Villous Hypertrophy Grades
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Synovial villous hypertrophy in the lateral subacromial space will be assessed arthroscopically and classified according to villous size as less than 2 mm, 2-5 mm, or greater than 5 mm. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Distribution of Subacromial Soft-Tissue Proliferation Grades
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Soft-tissue proliferation in the subacromial space will be assessed during arthroscopy and classified as absent, mild, or severe according to the predefined surgical CRF. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Presence of Arthroscopically Identified Acromial Spurs
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

The presence of acromial bony spurs will be assessed by arthroscopic observation and recorded as present or absent. The number and percentage of participants with acromial spurs will be reported.

During the arthroscopic surgery (intraoperative assessment)
Arthroscopically Assessed Rotator Cuff Tear Types
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Rotator cuff tears will be classified by arthroscopic assessment as partial-thickness or full-thickness tears. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Rotator Cuff Tear Size Categories According to the Cofield Classification
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Full-thickness rotator cuff tears will be classified according to the Cofield classification based on tear size: 1 cm or less, greater than 1 to 3 cm, greater than 3 to 5 cm, or greater than 5 cm. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Rotator Cuff Tendon Retraction Grades According to the Patte Classification
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Tendon retraction in applicable full-thickness rotator cuff tears will be assessed arthroscopically using the Patte classification (Grades I-III), based on the position of the retracted tendon relative to the greater tuberosity, humeral head, and glenoid. The number and percentage of participants in each grade will be reported.

During the arthroscopic surgery (intraoperative assessment)
Arthroscopic Rotator Cuff Tear Patterns
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Rotator cuff tear patterns will be assessed arthroscopically and classified according to the predefined surgical CRF, including crescent-shaped, L-shaped, reverse L-shaped, U/V-shaped, trapezoidal, or massive tear patterns. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Rotator Cuff Tendon Stump Color Categories
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

The color of the torn rotator cuff tendon stump will be assessed by direct arthroscopic observation and classified as white or red according to the predefined surgical CRF. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Intraoperative Rotator Cuff Tendon Quality Grades
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Rotator cuff tendon quality will be assessed by the operating surgeon using a predefined five-level ordinal scale: poor, fair, moderate, good, or excellent. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Number of Participants With Complete Rotator Cuff Repair
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Rotator cuff repair completeness will be assessed by the operating surgeon using a predefined surgical CRF. Repair status will be classified as complete or partial. The number and percentage of participants undergoing complete rotator cuff repair will be reported.

During the arthroscopic surgery (intraoperative assessment)
Intraoperative Rotator Cuff Repair Tension Grades
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Repair tension will be assessed by the operating surgeon during rotator cuff repair and classified into four categories: minimal or no tension, low tension, moderate tension, or high tension. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
Rotator Cuff Tendon Footprint Coverage Categories
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

Tendon footprint coverage following rotator cuff repair will be assessed intraoperatively and classified into five categories: less than 25%, 25-49%, 50-74%, 75-99%, or 100% coverage. The number and percentage of participants in each category will be reported.

During the arthroscopic surgery (intraoperative assessment)
anchors usage
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

the ways used in arthroscopic surgery, number of anchors.

During the arthroscopic surgery (intraoperative assessment)
Number of Differentially Expressed Genes in Rotator Cuff Tendon Tissue
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

RNA sequencing will be performed on surgically collected rotator cuff tendon specimens to characterize gene expression associated with rotator cuff tendinopathy. Differential gene expression will be assessed between prespecified clinical or molecular phenotype groups. The number of differentially expressed genes meeting predefined statistical significance criteria will be reported.

During the arthroscopic surgery (intraoperative assessment)
Number of Differentially Expressed Genes in Glenohumeral Capsular Tissue
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

RNA sequencing will be conducted on glenohumeral capsular tissue specimens collected during arthroscopic surgery. Differential gene expression will be evaluated between prespecified clinical or molecular phenotype groups to characterize capsular molecular alterations associated with rotator cuff disease. The number of differentially expressed genes meeting predefined statistical significance criteria will be reported.

During the arthroscopic surgery (intraoperative assessment)
Number of Differentially Expressed Genes in Rotator Interval Synovial Tissue
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

RNA sequencing will be performed on synovial tissue specimens obtained from the rotator interval during arthroscopic surgery. Differential gene expression will be assessed between prespecified clinical or molecular phenotype groups to investigate synovial changes associated with rotator cuff disease. The number of differentially expressed genes meeting predefined statistical significance criteria will be reported.

During the arthroscopic surgery (intraoperative assessment)
Number of Differentially Expressed Genes in Subacromial Bursa Tissue
Ramy czasowe: During the arthroscopic surgery (intraoperative assessment)

RNA sequencing will be performed on subacromial bursa tissue specimens collected during arthroscopic surgery. Differential gene expression will be assessed between prespecified clinical or molecular phenotype groups to characterize bursal molecular alterations associated with rotator cuff disease. The number of differentially expressed genes meeting predefined statistical significance criteria will be reported.

During the arthroscopic surgery (intraoperative assessment)
Number of Differentially Abundant Proteins in Plasma
Ramy czasowe: Baseline (preoperative blood collection)

Proteomic profiling will be performed on plasma samples collected before surgery to investigate circulating proteins associated with rotator cuff disease. Differential protein abundance will be assessed between prespecified clinical or molecular phenotype groups. The number of proteins meeting predefined criteria for differential abundance will be reported.

Baseline (preoperative blood collection)
Number of Genetic Variants Detected in Peripheral Blood DNA
Ramy czasowe: Baseline (preoperative blood collection)

Genomic DNA extracted from peripheral whole blood will undergo genomic sequencing to identify genetic variants potentially associated with rotator cuff disease. The number of genetic variants detected per participant according to predefined variant calling and quality-control criteria will be recorded and summarized across participants.

Baseline (preoperative blood collection)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 grudnia 2026

Zakończenie podstawowe (Szacowany)

1 grudnia 2036

Ukończenie studiów (Szacowany)

1 grudnia 2036

Daty rejestracji na studia

Pierwszy przesłany

8 listopada 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

15 listopada 2026

Pierwszy wysłany (Rzeczywisty)

20 listopada 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

20 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

15 listopada 2026

Ostatnia weryfikacja

1 listopada 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • SAHZU-2026-0928

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .